Topline Results: 18 Months of BAN2401 Might Work
The biotech company BioArctic Neuroscience announced positive topline results at the 18-month mark of a Phase 2b trial of BAN2401.
The biotech company BioArctic Neuroscience announced positive topline results at the 18-month mark of a Phase 2b trial of BAN2401.
Nurse, Brazilian, Social Media Guru and busy postdoc working in Nottingham to improve care and reduce risks in dementia.
Disclosing your health condition consists of two parts of a conversation: the disclosure itself and the request for support.
University of Westminster Postdoc Researcher working on the relation between nutrition and cognitive functions and helping people with MCI.
Our panel of award winning poster presenters provide tips and advice on what you can do to make your poster better than the rest
Could Join Dementia Research help recruit to your study? Meeting those essential targets
Race Against Dementia Dyson Fellow, understanding mechanisms of synapse loss and exploring ways to prevent it, at The University of Edinburgh.
In this blog Dr Nicolas Farina explores what it means to be ‘dementia’ friendly, and looks to the future and a dementia friendly society
Brighton and Sussex Medical School, interestsed in the benefits of physical activity, to identifying ways to maintain and improve people’s quality of life
You are coming towards the end of your PhD – so what next? There are many options open to you
Practical implications for nurses and healthcare professionals on engaging patients in co-creating effective digital health interventions.
Three guest blogs from Early Career Researchers, on their visit as an observer at the recent ARUK Grant Review Board